190 related articles for article (PubMed ID: 9022802)
1. Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
Hargreaves RH; Mayalarp SP; Butler J; McAdam SR; O'Hare CC; Hartley JA
J Med Chem; 1997 Jan; 40(3):357-61. PubMed ID: 9022802
[TBL] [Abstract][Full Text] [Related]
2. Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents.
Hargreaves RH; O'Hare CC; Hartley JA; Ross D; Butler J
J Med Chem; 1999 Jun; 42(12):2245-50. PubMed ID: 10377230
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking and sequence specific alkylation of DNA BY aziridinylquinones. 1. Quinone methides.
Mayalarp SP; Hargreaves RH; Butler J; O'Hare CC; Hartley JA
J Med Chem; 1996 Jan; 39(2):531-7. PubMed ID: 8558523
[TBL] [Abstract][Full Text] [Related]
4. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
Atwell GJ; Fan JY; Tan K; Denny WA
J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and DNA alkylation reactions of aziridinyl quinones: development of an efficient alkylating agent of the phosphate backbone.
Skibo EB; Xing C
Biochemistry; 1998 Oct; 37(43):15199-213. PubMed ID: 9790684
[TBL] [Abstract][Full Text] [Related]
6. Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.
Lee CS; Hartley JA; Berardini MD; Butler J; Siegel D; Ross D; Gibson NW
Biochemistry; 1992 Mar; 31(11):3019-25. PubMed ID: 1372518
[TBL] [Abstract][Full Text] [Related]
7. The DNA complexes of 2,5-diaziridinylbenzoquinone and 3,6-dimethyl-2,5-diaziridinylbenzoquinone. A molecular mechanics study.
Yuki M; Haworth IS
Anticancer Drug Des; 1993 Aug; 8(4):269-87. PubMed ID: 8240656
[TBL] [Abstract][Full Text] [Related]
8. DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.
Hartley JA; Berardini M; Ponti M; Gibson NW; Thompson AS; Thurston DE; Hoey BM; Butler J
Biochemistry; 1991 Dec; 30(50):11719-24. PubMed ID: 1751490
[TBL] [Abstract][Full Text] [Related]
9. DNA alkylation and interstrand cross-linking by treosulfan.
Hartley JA; O'Hare CC; Baumgart J
Br J Cancer; 1999 Jan; 79(2):264-6. PubMed ID: 9888467
[TBL] [Abstract][Full Text] [Related]
10. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of quinone-containing alkylating agents: DNA alkylation by aziridinylquinones.
Hargreaves RH; Hartley JA; Butler J
Front Biosci; 2000 Nov; 5():E172-80. PubMed ID: 11056081
[TBL] [Abstract][Full Text] [Related]
13. RecA-catalyzed, sequence-specific alkylation of DNA by cross-linking oligonucleotides. Effects of length and nonhomologous base substitutions.
Podyminogin MA; Meyer RB; Gamper HB
Biochemistry; 1996 Jun; 35(22):7267-74. PubMed ID: 8679556
[TBL] [Abstract][Full Text] [Related]
14. Mapping of DNA alkylation sites induced by aziridinylbenzoquinones in human cells by ligation-mediated polymerase chain reaction.
Lee CS; Pfeifer GP; Gibson NW
Cancer Res; 1994 Apr; 54(7):1622-6. PubMed ID: 8137269
[TBL] [Abstract][Full Text] [Related]
15. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
16. The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells.
Hasinoff BB; Begleiter A
Free Radic Res; 2006 Sep; 40(9):974-8. PubMed ID: 17015278
[TBL] [Abstract][Full Text] [Related]
17. DNA interstrand cross-linking, DNA sequence specificity, and induced conformational changes produced by a dimeric analog of (+)-CC-1065.
Ding ZM; Hurley LH
Anticancer Drug Des; 1991 Nov; 6(5):427-52. PubMed ID: 1662513
[TBL] [Abstract][Full Text] [Related]
18. Studies of pyrrolo[1,2-alpha]benzimidazolequinone DT-diaphorase substrate activity, topoisomerase II inhibition activity, and DNA reductive alkylation.
Skibo EB; Gordon S; Bess L; Boruah R; Heileman MJ
J Med Chem; 1997 Apr; 40(9):1327-39. PubMed ID: 9135030
[TBL] [Abstract][Full Text] [Related]
19. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.
Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA
J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of a novel DNA-DNA interstrand adenine-guanine cross-linking agent.
Zhou Q; Duan W; Simmons D; Shayo Y; Raymond MA; Dorr RT; Hurley LH
J Am Chem Soc; 2001 May; 123(20):4865-6. PubMed ID: 11457309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
